Purchase Order 75N91018P00735

The National Cancer Institute issued a purchase order to Li-Cor Biotech, LLC on June 12, 2026, for one Odyssey M Chemi/Fluor Imaging Bundle Standard imaging system, valued at $92,376.00 and due for completion by July 12, 2026. The acquisition was sole-source, non-competitive under FAR Parts 12 and 13, justified on a brand-name basis. Place of performance is Lincoln, Nebraska. The system includes four solid-state laser diodes (488, 520, 685, and 785 nm wavelengths), sCMOS fluorescence...

The National Cancer Institute issued a purchase order to Li-Cor, Inc. on June 12, 2026, for one LI-COR Biotech Odyssey M Chemi/Fluor Imaging Bundle Standard system valued at $92,376.00, with completion expected by July 12, 2026. The order is firm fixed price and carries no set-aside designation. Place of performance is Lincoln, Nebraska (the vendor's manufacturing location); delivery and installation occur at the National Cancer Institute's Laboratory of Human Carcinogenesis in Bethesda,...

<p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for a maintenance agreement valued at $5,250.00, effective February 14, 2018, with completion scheduled for February 21, 2019. Performance takes place in Lincoln, Nebraska. The order is a firm fixed-price maintenance agreement with no set-aside designation. Li-Cor, Inc., doing business as Li-Cor Bio Sciences, is a for-profit manufacturer of scientific instruments and analysis software.</p>

Li-Cor, Inc., doing business as Li-Cor Bio Sciences, has been awarded a $33,240 purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver an ODYSSEY XF data integrity bundle imaging system. Performance will occur in Lincoln, Nebraska over a five-week period concluding in mid-February 2024. The firm fixed price contract supports the NIH's research efforts to advance understanding of diseases such...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Li-Cor, Inc. (doing business as Li-Cor BioSciences) for an Odyssey M Bundle Imaging System. The system will be used to perform investigations related to the molecular biology of viruses, virus-host cell interactions, viral pathogenesis, and host defense mechanisms. The potential value of the award is...

<p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for $3,825.00 on February 21, 2018, with a completion date of March 26, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is for firm fixed-price scientific instruments and equipment, consistent with Li-Cor's specialization in manufacturing high-precision environmental monitoring and analytical instrumentation for federal research agencies.</p>

<p>The National Cancer Institute awarded a purchase order to Li-Cor, Inc. for $3,600.00 on June 26, 2018, with ultimate completion by June 30, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is a firm fixed-price purchase of scientific instrumentation or related equipment from the vendor's portfolio of environmental monitoring and analytical instruments.</p>

This purchase order awards Li-Cor, Inc. a contract valued at fifty-eight thousand eight hundred sixty-two dollars ($58,862) to provide one Odyssey DLx infrared imaging system and ten Empiria Studio Software licenses to the National Institutes of Health's National Center for Advancing Translational Sciences. The solicitation sought these products to support the Therapeutic Development Branch's ongoing collaborative projects through accurate identification of molecular mechanisms and cellular...

<p>The Office of Logistics and Acquisition Operations issued a delivery order to Li-Cor, Inc. on May 6, 2019, for an Odyssey CLX near-infrared imaging system with a ceiling value of $50,818.82 under the GSA Scientific Equipment and Services Schedule (FSS-66).</p> <p>Place of performance is Lincoln, Nebraska. The order is firm fixed price with an ultimate completion date of June 2, 2019.</p>

<p>The National Cancer Institute issued a $33,983.66 delivery order to Li-Cor, Inc. on May 11, 2018, under the GSA Schedule for Scientific Equipment and Services (FSS-66).</p> <p>Li-Cor, Inc., doing business as Li-Cor Bio Sciences, is a for-profit manufacturer of scientific instruments and analysis software. Place of performance is San Diego, CA 92121. The order was priced firm fixed price with no set-aside applied. Ultimate completion date is May 10, 2019.</p>